PDF] Effects of PDE type 5 inhibitors on Left Ventricular Diastolic Dysfunction in Resistant Hypertension

Cureus, Soluble Guanylate Cyclase Stimulators in Heart Failure

Cardiovascular Effects of the 3 Phosphodiesterase-5 Inhibitors Approved for the Treatment of Erectile Dysfunction

Coronary microvascular dysfunction: Implications in ischemic heart disease and therapeutic interventions - Browse Articles - Conditioning Medicine

PDF] Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study

JCI - Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice

Pharmaceuticals, Free Full-Text

Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles

PDF] Effects of PDE type 5 inhibitors on Left Ventricular Diastolic Dysfunction in Resistant Hypertension

Frontiers Pathogenesis of pulmonary hypertension caused by left heart disease